VANGUARD GROUP INC 13D and 13G filings for Caribou Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-30 10:58 am Sale | 2025-03-31 | 13G | Caribou Biosciences, Inc. CRBU | VANGUARD GROUP INC | 4,522,032 4.860% | -96,236 (-2.08%) | Filing |
| 2024-11-12 1:25 pm Unchanged | 2024-09-30 | 13G | Caribou Biosciences, Inc. CRBU | VANGUARD GROUP INC | 4,618,268 5.110% | 0 (Unchanged) | Filing |
| 2024-11-04 11:21 am Purchase | 2024-09-30 | 13G | Caribou Biosciences, Inc. CRBU | VANGUARD GROUP INC | 4,618,268 5.110% | 4,618,268 (New Position) | Filing |